Free Trial

Vigil Neuroscience (VIGL) SEC Filings & 10K Form

Vigil Neuroscience logo
$7.88 +5.57 (+241.13%)
Closing price 04:00 PM Eastern
Extended Trading
$7.88 0.00 (-0.06%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vigil Neuroscience SEC Filings

DateFilerForm TypeView
05/15/2025
3:42 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Vigil Neuroscience (Subject)
Form SCHEDULE 13G/A
05/07/2025
6:15 AM
Vigil Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
6:30 AM
Vigil Neuroscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/08/2025
11:15 PM
Vigil Neuroscience (Filer)
Form EFFECT
03/31/2025
6:46 AM
Vigil Neuroscience (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/31/2025
6:00 AM
Vigil Neuroscience (Filer)
Form DEF 14A
03/31/2025
6:05 AM
Vigil Neuroscience (Filer)
Form DEFA14A
03/31/2025
6:11 AM
Vigil Neuroscience (Filer)
Form ARS
03/13/2025
7:00 AM
Vigil Neuroscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2025
6:30 AM
Vigil Neuroscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
6:15 AM
Vigil Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
4:04 PM
Booth Bruce (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:04 PM
Gray David L. F. (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:08 PM
Magovcevic-Liebisch Ivana (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:09 PM
Bruhn Suzanne Louise (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:09 PM
Vigil Neuroscience (Issuer)
Ziolkowski Jennifer Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
6:15 AM
Vigil Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
5:42 PM
Magovcevic-Liebisch Ivana (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:44 PM
Budd Haeberlein Samantha L. (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:51 PM
Magovcevic-Liebisch Ivana (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:09 PM
Magovcevic-Liebisch Ivana (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
9:00 AM
Deep Track Capital, LP (Filed by)
Vigil Neuroscience (Subject)
Form SC 13G/A
11/07/2024
6:30 AM
Vigil Neuroscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:15 AM
Vigil Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
5:22 PM
Vida Ventures GP III, L.L.C. (Filed by)
Vigil Neuroscience (Subject)
Form SC 13D/A
09/19/2024
4:20 PM
Verni Christopher (Reporting)
Vigil Neuroscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2024
6:16 AM
Vigil Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
6:30 AM
Vigil Neuroscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:16 AM
Vigil Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:02 PM
Invus Global Management, LLC (Filed by)
Vigil Neuroscience (Subject)
Form SC 13G
07/24/2024
6:15 AM
Vigil Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
6:15 AM
Vigil Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:05 PM
Blanchard Cheryl R (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Budd Haeberlein Samantha L. (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Booth Bruce (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Koenig Gerhard (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Bruhn Suzanne Louise (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Thistle Mary (Reporting)
Vigil Neuroscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Vigil Neuroscience (Issuer)
Vitorovic Stefan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VIGL) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners